Abiopharma

New Form 8-K - GYRE THERAPEUTICS, INC. Filed: 2025-08-11 AccNo: 0000950170-25-106525 Size: 681 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits